Template:EBM review infobox
From Pubdrug
(List of links)
< Template:EBM review infoboxThe following pages link to here:
View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500).- Clinical trial review template (inclusion)
- User:W
- Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA) (inclusion)
- Carvedilol or Metoprolol European Trial (COMET) (inclusion)
- Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate (inclusion)
- Effect of risedronate on the risk of hip fracture in elderly women (HIP) (inclusion)
- Collaborative Atorvastatin Diabetes Study (CARDS) (inclusion)
- Intensive Blood-Glucose Control With Metformin (UKPDS 34) (inclusion)
- The PROactive Study: PROspective pioglitAzone Clinical Trial In macroVascluar Events (inclusion)
- Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) (inclusion)
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy (inclusion)
- Effect of Niacin on Lipid Levels and Glycemic Control in Patients With Diabetes: The ADMIT Study (inclusion)
- Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36) (inclusion)
- Renoprotective Effect of Irbesartan in Patients With Nephropathy due to Type 2 Diabetes (inclusion)
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38) (inclusion)
- Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM trial (inclusion)
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment in patients with type 2 diabetes (UKPDS 33) (inclusion)
- Intensive insulin treatment on long term survival after acute myocardial infarction in patients with type 2 diabetes (inclusion)
- Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes: the HOPE study and MICRO-HOPE substudy (inclusion)
- The Losartan Intervention For Endpoint reduction in hypertension study (LIFE) in diabetic patients (inclusion)
- MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in patients with diabetes (inclusion)
- Effects of long-term fenofibrate therapy on cardiovascular events in patients with type 2 diabetes (inclusion)
- Effect of lisinopril on mortality in diabetic patients with acute myocardial infarction (inclusion)
- Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes (inclusion)
- The Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication trial (DREAM) (inclusion)
- A Comparison of the Effects of Rosiglitazone and Glyburide on Cardiovascular Function and Glycemic Control in Patients with Type 2 Diabetes (inclusion)
- Cardiometabolic Risk in Impaired Fasting Glucose and Impaired Glucose Tolerance (inclusion)
- Glimepiride Combined with Morning Insulin Glargine, Bedtime Neutral Protamine Hagedorn Insulin, or Bedtime Insulin Glargine in Patients with Type 2 Diabetes: A Randomized, Controlled Trial (inclusion)
- Effects of Enalapril on Mortality in Severe Congestive Heart Failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) (inclusion)
- A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure (inclusion)
